Leptin-based therapy

About Neurotez

Neurotez is a clinical-stage biotech pioneering a metabolic approach to treating Alzheimer's disease, centered on Leptin, a hormone with demonstrated effects on key pathological hallmarks like amyloid-beta and tau. The company is advancing its lead Leptin-based therapeutic through preclinical and clinical development, targeting both treatment and prevention. With a seasoned leadership team and a clear focus on a large, unmet medical need, Neurotez aims to establish itself as a leader in CNS biotechnology, though it faces significant risks common to novel Alzheimer's therapies, including clinical, regulatory, and competitive challenges.

Therapeutic Areas